Skip to main content

Ypsomed Holding

Ypsomed Holding AG is a Swiss medical technology company specializing in the development and manufacture of injection and infusion systems for self-medication. The company designs and produces pre-filled pens, auto-injectors, pen needles, and automated infusion pumps for diabetes care, fertility treatments, and biopharmaceutical administration. Its operations encompass precision plastic injection molding, automated device assembly, and digital health software integration for patient monitoring. Revenue is derived primarily from supply contracts for medical injection devices sold to global pharmaceutical companies. Ypsomed holds a leading global position in self-injection systems for subcutaneous drug delivery. The company is headquartered in Burgdorf, Switzerland, and its shares trade on the SIX Swiss Exchange.

9 of the funds FundTelligence covers report a position in Ypsomed Holding.

Legal name
Ypsomed Holding AG
Sector
Health Care
Country
Switzerland
Funds holding it
9
Exposure themes
Diabetes Technology, Insulin Delivery, Obesity & Metabolic Health

Funds holding Ypsomed Holding

Showing the 8 largest of 9 funds holding it.

Loading...